- Meeting abstract
- Published:
Changes in serum cytokine levels during induced whole body hyperthermia
Critical Care volume 3, Article number: P082 (2000)
Background
Recent data from our laboratory demonstrated a significant decrease in the number of circulating T helper cells and monocytes as well as in the expression of IL-2. receptors on T cells during induced whole body hyperthermia [1,2]. The aim of further investigations was to analyze the influence of these effects on the function of TH1 cells, TH2 cells and monocytes. Therefore, we measured the levels of IL-2, IL-4, IL-6 and IFN-? in the blood of cancer-patients, undergoing whole body hyperthermia of 42°C. This is used as part of so called `systemische Krebs-Mehrschritt-Therapie' (sKMT) in our clinic.
Methods
Cytokine levels of 9 patients were measured by an ELISA technique. Blood samples were obtained before beginning of therapy at 37°C, at 40°C, at the end of the plateau of 42°C, at 37°C again, as well as after 20 h (on the next morning). Time between the first four investigations was about 2 h. Cytokine levels were compared by using a Wilcoxon rank sum test.
Conclusion
Despite a similar decrease in the number of both circulating T helper cells and monocytes, there seems to be a different change in the function of these cells during whole body hyperthermia up to 42°C. IL-2, which is postulated to be mainly produced in TH1 cells, decreased significantly; IL-4 and IFN-?, mainly produced in TH2 cells, decreased slightly and IL-6, one of the main products of monocytes, showed a significant increase. Further investigations are necessary to verify these results.
References
Critical Care 1998, 2 (Suppl. 1): 2.
BMA 1998, 80 (Suppl. 1): A301.
Acknowledgement
Supported by: Deutsche Krebshilfe, Deutsche Forschungsgemeinschaft (SFB 331, GraKo 273)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ahlers, O., Boehnke, T., Kerner, T. et al. Changes in serum cytokine levels during induced whole body hyperthermia. Crit Care 3 (Suppl 1), P082 (2000). https://doi.org/10.1186/cc456
Published:
DOI: https://doi.org/10.1186/cc456